DK0706393T3 - Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton - Google Patents

Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton

Info

Publication number: DK0706393T3
Authority: DK; Denmark
Prior art keywords: hexanoyl; immunosuppressive; oxo; homoserine lactone; antiallergic compounds
Prior art date: 1993-07-02

Application number

DK94919750T

Other languages

English (en)

Inventor

Barrie Walsham Bycroft

Herbert Fitzgerald Sewell

Paul Williams

Gordon Sydney Anderson Stewart

Original Assignee

Univ Nottingham

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-02

Filing date

1994-07-01

Publication date

2000-04-03

1994-07-01 Application filed by Univ Nottingham filed Critical Univ Nottingham

2000-04-03 Application granted granted Critical

2000-04-03 Publication of DK0706393T3 publication Critical patent/DK0706393T3/da

Links

150000001875 compounds Chemical class 0.000 title abstract 2
YRYOXRMDHALAFL-UHFFFAOYSA-N N-(3-oxohexanoyl)homoserine lactone Chemical compound CCCC(=O)CC(=O)NC1CCOC1=O YRYOXRMDHALAFL-UHFFFAOYSA-N 0.000 title 1
230000003266 anti-allergic effect Effects 0.000 title 1
230000001506 immunosuppresive effect Effects 0.000 title 1
125000006702 (C1-C18) alkyl group Chemical group 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Pulmonology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK94919750T 1993-07-02 1994-07-01 Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton DK0706393T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP93305221		1993-07-02
PCT/GB1994/001437 WO1995001175A1 (en)	1993-07-02	1994-07-01	Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone

Publications (1)

Publication Number	Publication Date
DK0706393T3 true DK0706393T3 (da)	2000-04-03

Family

ID=8214462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94919750T DK0706393T3 (da)	1993-07-02	1994-07-01	Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton

Country Status (11)

Country	Link
US (2)	US5776974A (da)
EP (1)	EP0706393B1 (da)
JP (1)	JP3434824B2 (da)
AT (1)	ATE184194T1 (da)
AU (1)	AU7077894A (da)
CA (1)	CA2166289A1 (da)
DE (1)	DE69420564T2 (da)
DK (1)	DK0706393T3 (da)
ES (1)	ES2139079T3 (da)
GR (1)	GR3032083T3 (da)
WO (1)	WO1995001175A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6936447B1 (en)	2000-04-03	2005-08-30	University Of Iowa Research Foundation	Autoinducer molecule
CA2294586C (en) *	1997-06-18	2009-01-27	The Research And Development Institute, Inc.	Homoserine lactones biofilm regulating compounds and their methods of use
US6455031B1 (en)	1997-06-18	2002-09-24	David G Davies	Methods and compositions for controlling biofilm development
ATE342661T1 (de) *	1997-06-18	2006-11-15	Univ Montana State	Homoserinlactone zum regulieren von biofilmen und methoden zur anwendung
US6054595A (en) *	1999-06-30	2000-04-25	Baylor University	Method for synthesis of N-homocysteine thiolactonyl retinamide
GB9924195D0 (en) *	1999-10-13	1999-12-15	Univ Nottingham	N-Acyl homoserine lactones for the treatment of cardiac tachyarrhythmias Ischaemic heart disease or congestive heart failure
GB0004530D0 (en) *	2000-02-25	2000-04-19	Univ Nottingham	Adjuvants
GB0007588D0 (en) *	2000-03-30	2000-05-17	Univ Nottingham	N-Acyl homoserine lactones
US6703513B1 (en) *	2000-06-02	2004-03-09	K-Quay Enterprises Llc	Production and use of derivatized homoserine lactones
AU2001286976A1 (en) *	2000-08-31	2002-03-13	East Carolina University	Novel autoinducer molecules and uses therefor
DK1361801T3 (da) *	2001-01-08	2007-10-08	Pathway Intermediates Ltd	Autoinducerforbindelser og deres anvendelser
GB0116312D0 (en) *	2001-07-04	2001-08-29	Univ Nottingham	"Compositions containing N-acyl homoserine lactones"
CA2450073C (en)	2001-07-25	2017-08-29	Biomarin Pharmaceutical Inc.	Compositions and methods for modulating blood-brain barrier transport
US6569887B2 (en) *	2001-08-24	2003-05-27	Dov Pharmaceuticals Inc.	(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
GB0122026D0 (en) *	2001-09-12	2001-10-31	Univ Nottingham	Insulitis
EP1450802A2 (en) *	2001-10-30	2004-09-01	The General Hospital Corporation	Methods for the prevention or treatment of bacterial and fungal infections
US7338969B2 (en)	2002-03-08	2008-03-04	Quonova, Llc	Modulation of pathogenicity
EP1768662A2 (en)	2004-06-24	2007-04-04	Novartis Vaccines and Diagnostics, Inc.	Small molecule immunopotentiators and assays for their detection
GB2418427A (en)	2004-09-02	2006-03-29	Univ Cambridge Tech	Ligands for G-protein coupled receptors
JP2008521878A (ja) *	2004-12-02	2008-06-26	ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー	非晶質アトルバスタチンの医薬組成物及びその製造のための方法
JP5133067B2 (ja) *	2005-02-04	2013-01-30	ウイスコンシンアラムナイリサーチファウンデーシヨン	クオラムセンシング細菌におけるコミュニケーション及び毒性を変更するための化合物及び方法
EP2671508B1 (en)	2005-04-28	2020-09-16	Proteus Digital Health, Inc.	Pharma-informatics system
GB0512238D0 (en) *	2005-06-15	2005-07-27	Univ Cambridge Tech	Anti-inflammatory agents
GB0610042D0 (en) *	2006-05-22	2006-06-28	Univ Nottingham	Substituted n-acyl homoserine lactones
JP2010503710A (ja)	2006-09-18	2010-02-04	ラプトールファーマシューティカルインコーポレイテッド	受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
WO2008116029A1 (en) *	2007-03-19	2008-09-25	Wisconsin Alumni Research Foundation	Modulation of bacterial quorum sensing with synthetic ligands
GB2452696B (en)	2007-08-02	2009-09-23	Cambridge Entpr Ltd	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
US7662967B2 (en) *	2007-08-02	2010-02-16	Cambridge Enterprise Limited	Anti-inflammatory compounds and compositions
EP2078713A1 (en)	2007-12-28	2009-07-15	QuoNova GmbH	Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
KR20180114970A (ko)	2009-05-06	2018-10-19	라보라토리 스킨 케어, 인크.	활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US8624063B2 (en)	2009-06-30	2014-01-07	Wisconsin Alumni Research Foundation	Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates
WO2017058757A1 (en) *	2015-10-01	2017-04-06	The University Of Toledo	Use of acyl-homoserine lactone derivatives as anti-thrombotic agents
US11247976B2 (en)	2016-04-29	2022-02-15	Wisconsin Alumni Research Foundation	Synthetic ligands that modulate the activity of the RhlR quorum sensing receptor
US10526278B2 (en)	2017-10-19	2020-01-07	Wisconsin Alumni Research Foundation	Inhibitors of quorum sensing receptor LasR
FR3102357B1 (fr) *	2019-10-23	2022-06-24	Univ Sorbonne	Analogues de n-acyl-homoserine lactones et composition pharmaceutique les comprenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2265355B1 (da) *	1974-03-28	1977-11-04	Blum Jean
FR2502153A1 (fr) *	1981-03-19	1982-09-24	Rech Pharmaceutiq Medicale	Acides (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthio) acetiques, leurs sels et leurs esters, leur procede de preparation et les compositions pharmaceutiques en contenant
IT1216556B (it) *	1988-04-07	1990-03-08	Poli Ind Chimica Spa	Derivati peptidici del3_aminodiidrotiofen_2_one, loro preparazione e impiego terapeutico.
GB9108307D0 (en) *	1991-04-18	1991-06-05	Univ Nottingham	Autoinducer
US5591872A (en) *	1993-08-09	1997-01-07	The University Of Iowa Research Foundation	Autoinducer molecule

1994
- 1994-07-01 DE DE69420564T patent/DE69420564T2/de not_active Expired - Fee Related
- 1994-07-01 AU AU70778/94A patent/AU7077894A/en not_active Abandoned
- 1994-07-01 DK DK94919750T patent/DK0706393T3/da active
- 1994-07-01 JP JP50337495A patent/JP3434824B2/ja not_active Expired - Fee Related
- 1994-07-01 CA CA002166289A patent/CA2166289A1/en not_active Abandoned
- 1994-07-01 AT AT94919750T patent/ATE184194T1/de not_active IP Right Cessation
- 1994-07-01 WO PCT/GB1994/001437 patent/WO1995001175A1/en not_active Ceased
- 1994-07-01 US US08/569,257 patent/US5776974A/en not_active Expired - Fee Related
- 1994-07-01 EP EP94919750A patent/EP0706393B1/en not_active Expired - Lifetime
- 1994-07-01 ES ES94919750T patent/ES2139079T3/es not_active Expired - Lifetime
1998
- 1998-06-15 US US09/097,371 patent/US5969158A/en not_active Expired - Lifetime
1999
- 1999-12-08 GR GR990403174T patent/GR3032083T3/el unknown

Also Published As

Publication number	Publication date
JPH08512048A (ja)	1996-12-17
US5776974A (en)	1998-07-07
WO1995001175A1 (en)	1995-01-12
AU7077894A (en)	1995-01-24
JP3434824B2 (ja)	2003-08-11
DE69420564D1 (de)	1999-10-14
DE69420564T2 (de)	2000-05-04
GR3032083T3 (en)	2000-03-31
US5969158A (en)	1999-10-19
EP0706393B1 (en)	1999-09-08
CA2166289A1 (en)	1995-01-12
ATE184194T1 (de)	1999-09-15
ES2139079T3 (es)	2000-02-01
EP0706393A1 (en)	1996-04-17

Publication	Publication Date	Title
GR3032083T3 (en)	2000-03-31	Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
NL1002835A1 (nl)	1996-10-14	Synergistisch stabilisatormengsel.
ATE168992T1 (de)	1998-08-15	7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
PT618190E (pt)	2004-08-31	9-¬glicil substituido)amido\|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
DE69325454D1 (de)	1999-07-29	Taxol-derivate
ES2088537T3 (es)	1996-08-16	Derivados de piranil cianoguanidina.
ATE269312T1 (de)	2004-07-15	N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
EP0705833A4 (en)	1997-04-02	DC-89 DERIVATIVES
DK0698606T3 (da)	1998-08-24	Azolylaminderivat
YU11997A (sh)	1999-09-27	Laktamski derivati i njihove farmaceutske kompozicije
ES2161713T3 (es)	2001-12-16	Derivado de metotrexato.
ATE99298T1 (de)	1994-01-15	1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.
NO930520L (no)	1993-08-16	Bifenyl-substituerte kinolinderivater
DK0404359T3 (da)	1994-07-25	Dibenzothiazepin-derivater, der er nyttige som antispasmodiske midler
TW333532B (en)	1998-06-11	Benzopyrans
ES2191763T3 (es)	2003-09-16	Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
DK0623131T3 (da)	1996-08-05	Alkylderivater af trazodon med CNS-aktivitet
ATE154598T1 (de)	1997-07-15	Carbamate des indan-pyrrolidins
ATE170862T1 (de)	1998-09-15	5-ht3 pyrrolopyrazinderivate
FI904449A0 (fi)	1990-09-10	N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
PT96564A (pt)	1991-10-15	Processo para a preparacao de um novo antibiotico, desoximulundocandina, e de composicoes farmaceuticas que o contem
TR200001122T2 (tr)	2000-08-21	Farmasötikler olarak bifenil türevleri.
ES2097435T3 (es)	1997-04-01	Derivados de 2,16-bispiperidinilandrostano monocuaternarios.
NO941697D0 (no)	1994-05-06	Nitroksyalkylamidderivater
SU1825499A3 (ru)	2011-02-10	Гидрохлорид n-(2-адамантил)гексаметиленимина, обладающий антикаталептической активностью